Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash from Financing Activities: 2020-2024

Historic Cash from Financing Activities for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to $819.6 million.

  • Core Scientific's Cash from Financing Activities fell 102.92% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $556.9 million, marking a year-over-year increase of 174.19%. This contributed to the annual value of $819.6 million for FY2024, which is 1935.58% up from last year.
  • Latest data reveals that Core Scientific reported Cash from Financing Activities of $819.6 million as of FY2024, which was up 1,935.58% from -$44.6 million recorded in FY2023.
  • In the past 5 years, Core Scientific's Cash from Financing Activities registered a high of $819.6 million during FY2024, and its lowest value of -$44.6 million during FY2023.
  • For the 3-year period, Core Scientific's Cash from Financing Activities averaged around $360.4 million, with its median value being $306.2 million (2022).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 114.58% in 2023, then surged by 1,935.58% in 2024.
  • Over the past 5 years, Core Scientific's Cash from Financing Activities (Yearly) stood at $40.7 million in 2020, then soared by 1,382.04% to $603.5 million in 2021, then slumped by 49.27% to $306.2 million in 2022, then plummeted by 114.58% to -$44.6 million in 2023, then skyrocketed by 1,935.58% to $819.6 million in 2024.